Clinical Trial Update: DLBS1033 for the Treatment of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating DLBS1033 for acute ischemic stroke was terminated, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DLBS1033 (DLBS1033)

Snippet

Sponsor: Dexa Medica Group | Conditions: Acute Ischemic Stroke | Phase 3 | Status: TERMINATED